Intech Investment Management LLC Moderna, Inc. Transaction History

Intech Investment Management LLC

$8.75 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $26.1 Million - $35.3 Million	305,609 Added 1212.93%	330,805 $35.3 Million
Q4 2023 Oct 18, 2024	SELL	$69.51 - $104.43 $5.4 Million - $8.11 Million	-77,684 Reduced 75.51%	25,196 $2.51 Million
Q4 2023 Feb 09, 2024	SELL	$69.51 - $104.43 $5.4 Million - $8.11 Million	-77,684 Reduced 75.51%	25,196 $2.51 Million
Q3 2023 Oct 18, 2024	SELL	$96.41 - $126.61 $22.5 Million - $29.5 Million	-233,205 Reduced 69.39%	102,880 $10.6 Million
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $22.5 Million - $29.5 Million	-233,205 Reduced 69.39%	102,880 $10.6 Million
Q2 2023 Oct 18, 2024	BUY	$118.5 - $160.53 $31.6 Million - $42.8 Million	266,888 Added 385.69%	336,085 $40.8 Million
Q2 2023 Aug 09, 2023	BUY	$118.5 - $160.53 $31.6 Million - $42.8 Million	266,888 Added 385.69%	336,085 $40.8 Million
Q1 2023 Oct 18, 2024	BUY	$135.66 - $197.02 $9.39 Million - $13.6 Million	69,197 New	69,197 $10.6 Million
Q1 2023 May 10, 2023	BUY	$135.66 - $197.02 $1.71 Million - $2.48 Million	12,599 Added 22.26%	69,197 $10.6 Million
Q4 2022 Oct 18, 2024	SELL	$118.38 - $210.04 $5.85 Million - $10.4 Million	-49,423 Reduced 46.62%	56,598 $10.2 Million
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $5.85 Million - $10.4 Million	-49,423 Reduced 46.62%	56,598 $10.2 Million
Q3 2022 Oct 18, 2024	BUY	$118.07 - $194.18 $12.5 Million - $20.6 Million	106,021 New	106,021 $12.5 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $19.2 Million - $31.5 Million	-162,236 Reduced 60.48%	106,021 $12.5 Million
Q2 2022 Aug 10, 2022	BUY	$117.13 - $176.59 $31.4 Million - $47.4 Million	268,257 New	268,257 $38.3 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.

Account